dr. wakelee on combining targeted agents for the treatment of lung cancer
Published 9 years ago • 104 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:32
dr. wakelee on immunotherapy versus targeted agents in nsclc
-
2:21
dr. wakelee on the rationale for immunotherapy in nsclc
-
1:22
recent advances in targeted agents for the treatment of lung cancer
-
2:18
dr. wakelee on first trial to combine antiangiogenesis agents with immunotherapy in nsclc
-
1:13
dr. wakelee discusses the future of lung cancer adjuvant therapy
-
1:35
dr. wakelee discusses maintenance therapy for patients with lung cancer
-
1:50
gracecastuc-065_lung_dr. wakelee on most promising new agents and pathways for treating lung cancer
-
5:29
what are the advantages of newer lung cancer treatment approaches?
-
1:35
dr. wakelee on unmet needs for immunotherapy in nsclc
-
1:04
dr. wakelee on the avaperl trial
-
1:23
dr. wakelee discusses current state of treatment in nsclc
-
1:14
gracecastuc 119 lung_dr. wakelee on targeted therapies generalizable to wider range of lung cancers
-
1:46
dr. wakelee on single-agent immunotherapy in nsclc
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
0:22
targeted therapies in lung cancer 2019
-
17:16
gracecast-028_lung-cancer_heather wakelee on nsclc adjuvant therapy
-
1:16
dr. wakelee on first-line therapy for egfr-mutant lung cancer
-
1:01:37
frontiers in oncology - heather wakelee, md
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents